JONATHAN HUBERMAN, a director at $CURI, sold 16,225 shares of the company on 08-26-2025 for an estimated $72,201. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 1,414,536 shares of this class of $CURI stock.
$CURI Insider Trading Activity
$CURI insiders have traded $CURI stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $CURI stock by insiders over the last 6 months:
- JOHN S HENDRICKS has made 0 purchases and 8 sales selling 8,650,000 shares for an estimated $31,262,521.
- CLINTON LARRY STINCHCOMB (President and CEO) has made 0 purchases and 2 sales selling 332,486 shares for an estimated $1,556,733.
- JONATHAN HUBERMAN has made 0 purchases and 3 sales selling 19,136 shares for an estimated $85,155.
- ANDREW HENDRICKS has made 0 purchases and 2 sales selling 4,000 shares for an estimated $19,208.
- PHILLIP BRADY HAYDEN (Chief Financial Officer) sold 1,000 shares for an estimated $4,890
- REBECCA R REED (Gen Counsel) sold 273 shares for an estimated $1,111
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CURI Hedge Fund Activity
We have seen 73 institutional investors add shares of $CURI stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,676,327 shares (+425.4%) to their portfolio in Q2 2025, for an estimated $9,437,721
- GEODE CAPITAL MANAGEMENT, LLC added 385,534 shares (+112.9%) to their portfolio in Q2 2025, for an estimated $2,170,556
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 357,718 shares (-88.0%) from their portfolio in Q2 2025, for an estimated $2,013,952
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 321,780 shares (+225.2%) to their portfolio in Q2 2025, for an estimated $1,811,621
- MILLENNIUM MANAGEMENT LLC removed 317,330 shares (-75.1%) from their portfolio in Q2 2025, for an estimated $1,786,567
- VANGUARD GROUP INC added 273,395 shares (+19.1%) to their portfolio in Q2 2025, for an estimated $1,539,213
- LAZARD ASSET MANAGEMENT LLC added 273,057 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,537,310
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CURI Analyst Ratings
Wall Street analysts have issued reports on $CURI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 05/07/2025
- Needham issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for $CURI, check out Quiver Quantitative's $CURI forecast page.
$CURI Price Targets
Multiple analysts have issued price targets for $CURI recently. We have seen 2 analysts offer price targets for $CURI in the last 6 months, with a median target of $5.75.
Here are some recent targets:
- Laura Martin from Needham set a target price of $5.5 on 08/06/2025
- James Goss from Barrington Research set a target price of $6.0 on 08/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
